US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Arovella Therapeutics Ltd (ALA) 銘柄情報

Arovella Therapeutics Ltd (ALA)

0.069

0.00

( 0.00% )

更新日時： 10:55:21

Arovella Therapeutics Ltd (ALA) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.069

( - )

買値

0.069

売値

0.07

出来高

300,081

0.068 日の範囲 0.069

0.065 52 週間の範囲 0.125

時価総額

前日終値

0.069

始値

0.069

時刻

最終取引時間

10:55:21

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 958,110

発行済株式数

1,208,783,672

配当利回り

PER

-10.17

1 株当たり利益 (EPS)

-0.01

歳入

3.21M

純利益

-7.93M

Arovella Therapeutics Limited, a biotechnology company, engages in the development of therapies for the treatment of cancer in Australia and internationally. It product pipeline includes ALA-101 CD19, which is a next-generation off-the-shelf CAR-iNKT cell therapy that targets CD19+ B cell lymphomas ... Arovella Therapeutics Limited, a biotechnology company, engages in the development of therapies for the treatment of cancer in Australia and internationally. It product pipeline includes ALA-101 CD19, which is a next-generation off-the-shelf CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukaemias; ALA-105 CLDN18.2 for targeting Claudin 18.2, which is expressed in gastric cancer, gastroesophageal junction cancer, pancreatic cancer, and lung and ovarian cancer; and IL-12-TM for treating solid tumors. The company was formerly known as Suda Pharmaceuticals Ltd and changed its name to Arovella Therapeutics Limited in October 2021. Arovella Therapeutics Limited was incorporated in 1999 and is based in Preston, Australia. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.arovella.com

本社

Preston, Australia

設立

1999

Arovella Therapeutics Ltd is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker ALA. The last closing price for Arovella Therapeutics was AUD0.07. Over the last year, Arovella Therapeutics shares have traded in a share price range of AUD 0.065 to AUD 0.125.

Arovella Therapeutics currently has 1,208,783,672 shares in issue. The market capitalisation of Arovella Therapeutics is AUD83.41 million. Arovella Therapeutics has a price to earnings ratio (PE ratio) of -10.17.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.002	-2.81690140845	0.071	0.073	0.066	631224	0.07015925	DE
4	-0.006	-8	0.075	0.079	0.066	728058	0.07248554	DE
12	-0.006	-8	0.075	0.093	0.065	994439	0.07561624	DE
26	-0.01	-12.6582278481	0.079	0.1	0.065	1010489	0.08166067	DE
52	-0.008	-10.3896103896	0.077	0.125	0.065	1253445	0.08803376	DE
156	0.023	50	0.046	0.21	0.043	1750690	0.1060725	DE
260	0.02	40.8163265306	0.049	0.21	0.02	1754601	0.08560385	DE

ALA - Frequently Asked Questions (FAQ)

What is the current Arovella Therapeutics Ltd share price?

The current share price of Arovella Therapeutics Ltd is AUD 0.069

How many Arovella Therapeutics Ltd shares are in issue?

Arovella Therapeutics Ltd has 1,208,783,672 shares in issue

What is the market cap of Arovella Therapeutics Ltd?

The market capitalisation of Arovella Therapeutics Ltd is AUD 83.41M

What is the 1 year trading range for Arovella Therapeutics Ltd share price?

Arovella Therapeutics Ltd has traded in the range of AUD 0.065 to AUD 0.125 during the past year

What is the PE ratio of Arovella Therapeutics Ltd?

The price to earnings ratio of Arovella Therapeutics Ltd is -10.17

What is the cash to sales ratio of Arovella Therapeutics Ltd?

The cash to sales ratio of Arovella Therapeutics Ltd is 25.99

What is the registered address of Arovella Therapeutics Ltd?

The registered address for Arovella Therapeutics Ltd is Corporate One, Preston, Victoria, 3072

What is the Arovella Therapeutics Ltd website address?

The website address for Arovella Therapeutics Ltd is www.arovella.com

Which industry sector does Arovella Therapeutics Ltd operate in?

Arovella Therapeutics Ltd operates in the Biotechnology & Life Sciences sector

gmac8625

gmac8625 4分前

All good, natural questions. It would seemingly be the biggest blunder ever if they don’t do anything we have full capitulation right now and the stars seem to be aligned (or very close to). It is harder to come up with an excuse not to right now….my fear is the admin trying to be so cute to maximi

peafunke

peafunke 5分前

Let’s go. Next two weeks it is. But should see what’s behind door number one end of week 🤞🤞🤞

I leave for a bit and…. ;)

raiderz

raiderz 9分前

HIRU was so blatant with their promotion they earned a warning badge from OTC in fall of 2024.

After that, a set of paid accounts rotated in and out pumping HIRU here, on X, and stocktwts.

Where’s the goldenpump? Gone from here, and x. For someone who likes “cheapies”

DJurg

They sold 10.9M shares last quarter - and 4.1 M SO FAR this quarter - so they are by no means done selling shares

Duke Knockem

Duke Knockem 10分前

CHME is not current yet, but I'm expecting to see the fillings appearing really soon. next step should be the shell badge appearance on the OTC market website. I'm not too sure what is Belisarian strategy there ...they have encc and Zhud current and soon chme and AHFI ....yet they struggle to find a

Zardiw

Zardiw 11分前

$INHD - #DDAmanda Chart.

https://DDAmanda.com/Charts/DDAmandaINHD.jpg

https://DDAmanda.com

Z

Zardiw

Zardiw 11分前

$INHD - #DDAmanda Chart.

https://DDAmanda.com/Charts/DDAmandaINHD.jpg

https://DDAmanda.com

Z

Zardiw

Zardiw 13分前

$INHD traded like $5 Billion today..........

Z

Zardiw

Zardiw 13分前

Lotta manipulation on $INHD today..........

Z

gfp927z

gfp927z 13分前

Bigworld, It turns out that Musk has set aside 30% of the Space-X IPO offering to go to retail investors. In most IPOs it is only 5-10% for retail, so this is very unusual. Either there wasn't enough demand for shares from institutions (?), or he wants to have small fry retail involved to broaden

Zardiw

Zardiw 14分前

$INHD - #DDAmanda Chart.

https://DDAmanda.com/Charts/DDAmandaINHD.jpg

https://DDAmanda.com

Z

shajandr

shajandr 14分前

"The trend is now my friend!"
Great call, Chuckles.

https://investorshub.advfn.com/uimage/uploads/2026/6/8/qbkngmgtichrt.JPG

Duke Knockem

Duke Knockem 15分前

could be Belisarian....they are already planning the next pump. Dilan might get the shell back and then promote azrh again for a future merger. Being in his position I know I would....

janice shell

janice shell 16分前

How math can help you decide what to order for dinner

An experiment with 2,520 participants backs Richard Feynman’s answer to every diner’s dilemma: do I want to try something new?

BY DAVIDE CASTELVECCHI & NATURE MAGAZINE

https://removepaywalls.com/https:

stoxjock

stoxjock 19分前

Scumbag Fraudster EX-Hedge Fund Manager Whitney Tilson is having the same issue....He is scared of the Day of Reckoning when LBHI's BK Case is "Closed' and LBHI 'merges' as an "Ongoing Concern" Investment Bank again!

StonkMaster

StonkMaster 21分前

New Northwest Biotherapeutics sponsored trial:
https://clinicaltrials.gov/study/NCT07634094

NovaWahoo

NovaWahoo 23分前

R BLAGGY IS A CON-MAN

WHERE’S THE BEEF?

SCAM 🚨 SCAM 🚨 SCAM 🚨

HOW MANY BILLIONS IN FLOAT?

BACK TO .0001 TOMORROW

rickn23

rickn23 23分前

What If Hydrogen Didn't Need 700 Bar

https://www.youtube.com/watch?v=VI4tI_nUfOk

thehawk72

thehawk72 23分前

Since inception, they haven't had anything substantial. They're going into AI? Put a couple questions regarding WDLF into an AI engine, and beware of the results. AI is not too keen on WDLF and the business model throughout their history.

BiotechAce

BiotechAce 24分前

I agree people should do their DD and investigate before investing.

I wonder what long list of psychiatric conditions Tony would be diagnosed with if he were evaluated? I bet it would be a dandy of a long list. I hope his wife, children and grandchildren are proud of him. He is a rea

JRyan

That is funny. 😁

stoxjock

stoxjock 26分前

So, what are you suggesting? It is being 'shorted' so *Insiders* can 'scoop up' the Cheap shares OR are you saying we could expect these shares will be given to "WamU Escrow-holders for our Assets?

GLTU & GLTA WaMu Escrow-Holders!

Boston-Bets

Boston-Bets 29分前

I'm "down" from Jan peak over 1/2 a Bingo, but it's all on paper, so...

biosectinvestor

biosectinvestor 29分前

Your post has major factual and legal problems.

First, there is no public evidence that NWBO received a CHM letter. None. You do not cite a document, an MHRA statement, a company disclosure, a leak, or any factual source. Your entire argument begins with an unsupported negative regula

Arovella Therapeutics

Euronext Euro 50 ESG EW ...

Ci Global Alpha Innovato...

Oceanpact Servicos Marit... ON

Kartoon Studios

Digital Network

Helvetia Baloise (PK)

Bmo Managed Equity Growt...

Asian Development Bank

Nordea 1 Norwegian

United Tennessee Banksha... (QB)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。